Brii Biosciences (HKSE:02137) Price-to-Tangible-Book : 0.25 (As of Jun. 23, 2024)

View and export this data going back to 2021. Start your Free Trial

What is Brii Biosciences Price-to-Tangible-Book?

As of today (2024-06-23), Brii Biosciences's share price is HK$1.09. Brii Biosciences's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was HK$4.28. Hence, Brii Biosciences's Price to Tangible Book Ratio of today is 0.25.

The historical rank and industry rank for Brii Biosciences's Price-to-Tangible-Book or its related term are showing as below:

HKSE:02137' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 0.25 Med: 1.57 Max: 5.83
Current: 0.25

During the past 5 years, Brii Biosciences's highest Price to Tangible Book Ratio was 5.83. The lowest was 0.25. And the median was 1.57.

HKSE:02137's Price-to-Tangible-Book is ranked better than
97.93% of 1209 companies
in the Biotechnology industry
Industry Median: 2.63 vs HKSE:02137: 0.25

A closely related ratio is called PB Ratio. As of today, Brii Biosciences's share price is HK$1.09. Brii Biosciences's Book Value per Sharefor the quarter that ended in Dec. 2023 was HK$4.68. Hence, Brii Biosciences's P/B Ratio of today is 0.23.

Brii Biosciences Price-to-Tangible-Book Historical Data

The historical data trend for Brii Biosciences's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Brii Biosciences Price-to-Tangible-Book Chart

Brii Biosciences Annual Data

Trend

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

5.83

1.57

0.53

Brii Biosciences Semi-Annual Data
	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial				5.83	1.63	1.57	0.70	0.53

Competitive Comparison of Brii Biosciences's Price-to-Tangible-Book

For the Biotechnology subindustry, Brii Biosciences's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Brii Biosciences's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Brii Biosciences's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Brii Biosciences's Price-to-Tangible-Book falls into.

Brii Biosciences Price-to-Tangible-Book Calculation

Brii Biosciences's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	1.09	/	4.276
	=	0.25

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Brii Biosciences Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Brii Biosciences's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Brii Biosciences (HKSE:02137) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Brii Biosciences Ltd (HKSE:02137) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

BRIBF:USA 7SS:Germany

Address

No. 1 North Yongtaizhuang Road, 3rd Floor, Building 7, Zhongguancun Dongsheng, International Science Park, Haidian District, Beijing, CHN, 100192

Website

https://www.briibio.com

Brii Biosciences Ltd is a biotechnology company based in China and the United States. It is committed towards developing advancing therapies for infectious diseases, such as HBV, HIV, MDR/XDR gram-negative infections, and other illnesses, such as the CNS diseases, which have public health burdens in China and worldwide. The company's pipeline of products includes more than 10 product candidates that focus on infectious diseases and mental illnesses.

Executives

Hong Zhi	2101 Beneficial owner
Xyxy Holdings Ltd.	2201 Interest of corporation controlled by you
Booming Passion Limited	2101 Beneficial owner
Boyu Capital Fund Iii, L.p.	2201 Interest of corporation controlled by you
Boyu Capital General Partner Iii, L.p.	2201 Interest of corporation controlled by you
Boyu Capital General Partner Iii, Ltd	2201 Interest of corporation controlled by you
Tong Xiaomeng	2201 Interest of corporation controlled by you
Boyu Group, Llc	2201 Interest of corporation controlled by you
Boyu Capital Group Holdings Ltd	2201 Interest of corporation controlled by you
Jpmorgan Chase & Co.	2201 Interest of corporation controlled by you
Invesco Advisers, Inc.	2102 Investment manager
Ma Yun	2201 Interest of corporation controlled by you
Yunfeng Investment Iii, Ltd.	2201 Interest of corporation controlled by you
Yunfeng Fund Iii, L.p.	2201 Interest of corporation controlled by you
Yf Bright Insight Limited	2101 Beneficial owner

Brii Biosciences (HKSE:02137) Headlines

No Headlines